51 – 60 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials
(
- Contribution to journal › Scientific review
-
Mark
Optimal Blood Pressure Target in Diabetic and Nondiabetic Hypertensive Patients
(
- Contribution to journal › Article
-
Mark
Three-year recurrence of Dupuytren’s contracture after needle fasciotomy and collagenase injection : a two-centre randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
(
- Contribution to journal › Article
- 2017
-
Mark
Comparison of eye movement desensitization and reprocessing therapy, cognitive behavioral writing therapy, and wait-list in pediatric posttraumatic stress disorder following single-incident trauma: a multicenter randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome
(
- Contribution to journal › Article
-
Mark
Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg
(
- Contribution to journal › Article
-
Mark
Effects of a culturally adapted lifestyle intervention on cardio-metabolic outcomes : a randomized controlled trial in Iraqi immigrants to Sweden at high risk for Type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Treatment outcome in orthognathic surgery-A prospective randomized blinded case-controlled comparison of planning accuracy in computer-assisted two- and three-dimensional planning techniques (part II)
(
- Contribution to journal › Article
-
Mark
Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants : Evaluation of feasibility in a phase II study
(
- Contribution to journal › Article